Analyst Ratings For NASDAQ:AUPH – Isotechnika Pharma (NASDAQ:AUPH)
Today, HC Wainwright reiterated its Buy rating on NASDAQ:AUPH – Isotechnika Pharma (NASDAQ:AUPH) with a price target of $12.00.
Some recent analyst ratings include
- 5/2/2018-HC Wainwright Reiterated Rating of Buy.
- 3/16/2018-Seaport Global Securities Reiterated Rating of Buy.
- 2/8/2018-Royal Bank of Canada initiated coverage with a Outperform rating.
- 4/11/2017-FBR & Co Reiterated Rating of Outperform.
Recent Trading Activity for NASDAQ:AUPH – Isotechnika Pharma (NASDAQ:AUPH)
Shares of NASDAQ:AUPH – Isotechnika Pharma closed the previous trading session at 5.26 down -0.01 0.19% with 5.159999847412109 shares trading hands.